Furthermore, the lncRNA GATA3-AS1 has been described as a potential biomarker of NAC response in luminal B breast cancer patients, and it has been identified using RNA-Seq transcriptome analysis and validated using RT-qPCR [27]. Here, GATA3 is linked to breast carcinoma.